Electronic prescribing allows you to write prescriptions from your computer, and either print them or, in some areas, transmit them directly to a pharmacy. There are many advantages to the practitioner and the patient.
You’ve probably heard that looking for something on the internet is like taking a drink from a fire hydrant…. We’ve made it a bit easier by describing a few of our favorite websites.
John Luo, MD
Assistant Professor of Psychiatry UCLA School of Medicine
Past President, American Association for Technology in Psychiatry (www.techpsych.org)
Dr. Luo has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.
Dr. Luo, you are one of the nation’s experts in how psychiatrists can use computer technology in their practice. When did you first get involved with using computers in psychiatry?
John M. Grohol, PsyD
Dr. Grohol is CEO, PsychCentral.com, and author, The Insider’s Guide to Mental Health Resources Online (Guilford, 2003).
Dr. Grohol has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.
Dr. Grohol, you frequently speak on the use of e-mail in clinical practice. Can you give us some guidelines for how we should most appropriately use e-mail with our patients?
Shalom Feinberg, MD
Associate Clinical Professor of Psychiatry, Albert Einstein College of Medicine and private practice, Queens, New York
Dr. Feinberg has disclosed that he has no financial interests in any commercial companies pertaining to this educational activity.
EMSAM is here! Let us begin with a question that has been on everybody’s mind: Why is it named “EMSAM?"
The MAOIs were first introduced in the mid-1950s, and for the first decade of their use, nobody had an inkling that combining them with cheese (or any other high tyramine food) could be dangerous.
Arguably, the most confusing thing about MAOIs is keeping track of which medication is “tranylcypromine” and which is “phenelzine.” The following mnemonics work for Dr. Carlat, and perhaps they will for you.
Jonathan Cole, MD
Professor of Psychiatry, Harvard Medical School, Senior Consultant, McLean Hospital
Dr. Cole has disclosed that he has no consultant, speaking, or grant support relationships with any commercial companies pertaining to this educational activity. He has disclosed that he owns stock in both Pfizer and Bristol-Myers Squibb. Dr. Cole has disclosed that psychostimulants and oral selegiline have not been approved by the U.S. Food and Drug Administration for use in the treatment of depression. Please consult product labeling for the approved uses. Dr. Carlat has reviewed the content of the interview and has determined that there is no commercial bias present.
Dr. Cole, you have been involved in some of the seminal research in psychopharmacology over the years, including some of the early studies of MAOIs. One of the things that I’ve heard is that the early studies of MAOIs were not very impressive. Is that true?